iShares iBonds Dec 2035 Term Treasury ETFIBTQ

The iShares iBonds Dec 2035 Term Treasury ETF (IBTQ) is a maturity-date ETF designed to hold US Treasury securities maturing on or before 31 December 2035, then return principal to shareholders. The fund’s mandate is simple: deliver a predictable 2035 maturity without the need to select individual bonds or forecast interest-rate paths. The issuer’s UK marketing pages describe iShares as the world’s largest ETF provider, but the IBTQ wrapper is less about innovation and more about a mechanical maturity ladder of US Treasuries. The fund’s holdings are fixed by maturity date, not by any algorithm’s view of value, which makes the issuer’s ‘AI ETF’ branding feel like a creative stretch for a portfolio of plain-vanilla government paper.

The fund’s expense ratio is 0.07%, which is less than the cost of a London coffee if you annualise it, but it is still a recurring charge for a portfolio that’s just a ladder of US Treasuries maturing on a fixed date. The issuer’s UK product pages note that most of the protections provided by the UK regulatory system do not apply to the operation of the iShares products and that compensation will not be available under the UK Financial Services Compensation Scheme in the event of their default. For investors seeking UK regulatory comfort, those pages are worth reading twice. The fund trades under ticker IBTQ on Nasdaq, where the market page shows live quotes, volume, and basic trading data, but the real substance is in the holdings and the fee clock ticking toward the 2035 maturity.

The fund’s top holdings, as implied by its mandate and typical iBonds construction, are US Treasuries maturing in 2033, 2034, and 2035, with the bulk allocated to the 2035 maturity. The issuer’s AI ETF marketing pages feature gleaming machinery and confident prose about capturing innovation, but IBTQ’s reality is a slow-motion waltz of zeros and ones in a government-securities tango. The issuer’s product pages repeatedly remind readers that the protections provided by the UK regulatory system do not apply, which is a polite way of saying, ‘Read the prospectus, not the AI brochure.’ The AUM figure isn’t plastered on the homepage, but the SEC filing will tell you how many investors are actually on this bridge to the future.

On Nasdaq’s IBTQ market activity page, the ETF shows live price, volume, and basic trading data. The fund’s mandate and construction mean the chart will likely show a slow, steady drift toward the 2035 maturity date rather than dramatic price swings, unless yields move sharply. There are no moving averages or valuation commentary here-just a maturity date and a fee. The fund’s prospectus promises to ‘distribute net investment income monthly,’ which matters only if you enjoy the rhythm of small, predictable cash flows rather than the drama of AI’s next breakthrough. The issuer’s UK product pages caution that most UK regulatory protections don’t apply, so the source directs readers to treat IBTQ like any other unsecured exposure.

The fund’s expense ratio is 0.07%, which is less than the cost of forgetting to cancel a subscription, but it’s still a recurring charge for a portfolio that’s just a ladder of US Treasuries. The issuer’s AI ETF marketing promises to ‘leverage industry-leading research and insights,’ yet IBTQ’s holdings are mechanically selected by maturity date, not by any algorithm’s view of value. The SEC filing for IBTQ will reveal the fund’s actual holdings and concentration, but the issuer’s marketing pages for AI ETFs are a creative stretch for a portfolio of plain-vanilla government paper. The fund’s Nasdaq page shows it trading under ticker IBTQ, which is perfect if you enjoy the poetry of three letters standing in for a pile of bonds maturing in nine years.